LCML
MDT icon

Lionhunter Capital Management, LLC’s Medtronic MDT Stock Holding History

Lionhunter Capital Management, LLC’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1M Buy
+14,104
New +$1.14M 0.5% 52

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Lionhunter Capital Management, LLC's MDT Position: Q2 2026 in Review

Lionhunter Capital Management, LLC opened a new position in Medtronic (MDT) in Q2 2026: 14,104 shares worth $1.1M. The stake represents 0.5% of the portfolio and ranks #52 among its holdings.

1,796 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Lionhunter Capital Management, LLC held 14,104 shares of Medtronic worth $1.1M as of Q2 2026.
  • Medtronic was a new Lionhunter Capital Management, LLC position in Q2 2026.
  • Medtronic made up 0.5% of Lionhunter Capital Management, LLC's portfolio in Q2 2026, its #52 holding.
  • 1,796 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Lionhunter Capital Management, LLC's 13F filing for Q2 2026, filed 13 Aug 2026.